AGA Medical Holdings, Inc.
5050 Nathan Lane North
Plymouth,
MN 55442
United States - Map
Phone: 763-513-9227
Fax: 763-513-9226
Web Site: http://www.amplatzer.com
| AGA Medical Holdings, Inc., through its subsidiaries, engages in the development, manufacture, and marketing of medical devices for the treatment of structural heart defects and vascular abnormalities primarily in the United States and Europe. The company provides structural heart defect products to interventional cardiologists and electro physiologists; and vascular products to vascular surgeons and interventional radiologists. Its structural heart defect product line comprises AMPLATZER Septal Occluders for the closure of holes; AMPLATZER Duct Occluder intended for the closure of patent ductus arteriosus; AMPLATZER Ventricular Septal Defect (VSD) Occluders to address membranous and muscular VSDs; AMPLATZER patent foramen ovale (PFO) Occluder for the closure of PFOs; and AMPLATZER Cardiac Plug for occlusion of the left atrial appendage. The companys devices for vascular diseases comprise AMPLATZER Vascular Plugs for closure of abnormal blood vessels; and AMPLATZER Vascular Grafts for the treatment of iliac artery aneurysms. AGA Medical Holdings, Inc. was founded in 1995 and is headquartered in Plymouth, Minnesota. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. John R. Barr , 53
Chief Exec. Officer and Pres |
$
891.00K |
$
0 | Mr. Franck Gougeon , 44
Co-Founder, Member of the Management Board, Director, Chairman of Corp. Devel. Committee and Member of Compensation Committee |
$
733.00K |
$
0 | Ms. Brigid A. Makes , 54
Chief Financial Officer and Principal Accounting Officer |
$
398.00K |
$
0 | Mr. Ronald E. Lund , 75
Chief Legal Officer, Sr. VP, Sec. and Gen. Counsel |
$
680.00K |
$
0 | Dr. Kurt Amplatz M.D., 86
Co-Founder and R&D Consultant |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.36% Nasdaq 
Profile
